Full Name | Nicole Stone |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 395 Mass Ave, Acton, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225775927 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
Provider Name | Achieve Physical Therapy Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1922297886 PECOS PAC ID: 0042392052 Enrollment ID: O20080130000244 |
News Archive
Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that although hemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early.
A study estimates that total annual costs for five major health care-associated infections (HAIs) were $9.8 billion, with surgical site infections contributing the most to overall costs, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
Researchers from RUDN University conducted an effective three-component reaction, obtaining unusual organic compounds. The latter are structurally similar to a number of biologically active compounds - which makes it possible to use them in pharmaceutics.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Nicole Stone, 411 Mass Ave Ste 302, Acton, MA 01720-3739 Ph: (978) 263-0007 | Nicole Stone, 395 Mass Ave, Acton, MA 01720-3733 Ph: (978) 263-0007 |
News Archive
Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that although hemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early.
A study estimates that total annual costs for five major health care-associated infections (HAIs) were $9.8 billion, with surgical site infections contributing the most to overall costs, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
Researchers from RUDN University conducted an effective three-component reaction, obtaining unusual organic compounds. The latter are structurally similar to a number of biologically active compounds - which makes it possible to use them in pharmaceutics.
› Verified 3 days ago
Kathryn Elizabeth Garabadian, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 395 Mass Ave, Acton, MA 01720 Phone: 978-263-0007 Fax: 978-263-0014 | |
Michael Tang, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 395 Mass Ave, Acton, MA 01720 Phone: 978-263-0007 Fax: 978-263-0014 | |
Mr. Robert E Thomas, MSPT, LATC Physical Therapist Medicare: Medicare Enrolled Practice Location: 411 Mass Ave, Suite 302, Acton, MA 01720 Phone: 978-263-0007 Fax: 978-263-0014 | |
John Mark Resteghini, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 411 Massachusetts Ave, Suite 302, Acton, MA 01720 Phone: 978-263-0007 Fax: 978-263-0014 | |
Five Star Sports Rehab & Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 30 Great Rd Ste 105, Acton, MA 01720 Phone: 978-287-0212 | |
Steven Bowen, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 411 Mass Ave Ste 302, Acton, MA 01720 Phone: 978-263-0007 Fax: 978-263-0014 | |
Stephen Bosjlie, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 411 Mass Ave Ste 302, Acton, MA 01720 Phone: 978-263-0007 Fax: 978-263-0014 |